Carisma Therapeutics Inc.

PHILADELPHIA, June 5, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several investor conferences in June 2023. These investor conferences include: Jefferies Global Healthcare Conference Steven Kelly, President and Chief Executive Officer, … Read more

PHILADELPHIA, May 30, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several healthcare industry conferences in June 2023. These conferences include: 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Yara Abdou, … Read more